These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16438040)

  • 21. Mononucleoside SATE glucosyl phosphorothiolates as a new series of pronucleotides.
    Jochum A; Schlienger N; Gosselin G; Imbach JL; Aubertin AM; Périgaud C
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):899-901. PubMed ID: 14565306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemistry of bisSATE mononucleotide prodrugs.
    Peyrottes S; Périgaud C
    Curr Protoc Nucleic Acid Chem; 2007 Jun; Chapter 15():Unit 15.3. PubMed ID: 18428973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipid derivatives of cladribine and fludarabine: synthesis and biological properties.
    Tsybulskaya I; Kulak T; Kalinichenko E; Baranovsky A; Bogushevich S; Golubeva M; Kuzmitsky B
    Bioorg Med Chem; 2015 Jul; 23(13):3287-96. PubMed ID: 25960323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spiral assembly of amphiphilic cytarabine prodrug assisted by probe sonication: Enhanced therapy index for leukemia.
    Liu J; Ma N; Zhao D; Li Z; Luan Y
    Colloids Surf B Biointerfaces; 2015 Dec; 136():918-27. PubMed ID: 26551869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P.
    Shirali A; Sriram M; Hall JJ; Nguyen BL; Guddneppanavar R; Hadimani MB; Ackley JF; Siles R; Jelinek CJ; Arthasery P; Brown RC; Murrell VL; McMordie A; Sharma S; Chaplin DJ; Pinney KG
    J Nat Prod; 2009 Mar; 72(3):414-21. PubMed ID: 19161336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of fatty acyl ester derivatives of cytarabine as anti-leukemia agents.
    Chhikara BS; Mandal D; Parang K
    Eur J Med Chem; 2010 Oct; 45(10):4601-8. PubMed ID: 20692740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of new mononucleotide prodrugs: aryl (SATE) phosphotriester derivatives.
    Peyrottes S; Schlienger N; Beltran T; Lefebvre I; Pompon A; Gosselin G; Aubertin AM; Imbach JL; Périgaud C
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):315-21. PubMed ID: 11563043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside.
    Jung KY; Hohl RJ; Wiemer AJ; Wiemer DF
    Bioorg Med Chem; 2000 Oct; 8(10):2501-9. PubMed ID: 11058045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice.
    Koller-Lucae SK; Suter MJ; Rentsch KM; Schott H; Schwendener RA
    Drug Metab Dispos; 1999 Mar; 27(3):342-50. PubMed ID: 10064564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and study of a new series of phosphoramidate derivatives as mononucleotide prodrugs.
    Egron D; Périgaud C; Gosselin G; Aubertin AM; Imbach JL
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):751-4. PubMed ID: 11563108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
    Pettit GR; Lippert JW
    Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neighboring group catalysis in the design of nucleotide prodrugs.
    Khamnei S; Torrence PF
    J Med Chem; 1996 Sep; 39(20):4109-15. PubMed ID: 8831776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.
    Pettit GR; Orr B; Ducki S
    Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
    Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
    Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prodrugs of aza nucleosides based on proton transfer reaction.
    Karaman R
    J Comput Aided Mol Des; 2010 Dec; 24(12):961-70. PubMed ID: 20941527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric prodrug for release of an antitumoral agent by specific enzymes.
    Cavallaro G; Pitarresi G; Licciardi M; Giammona G
    Bioconjug Chem; 2001; 12(2):143-51. PubMed ID: 11312674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of cytarabine prodrugs and delivery systems for leukemia treatment.
    Chhikara BS; Parang K
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1399-414. PubMed ID: 20964588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic characteristics of L-valyl-ara-C and its implication on the oral delivery of ara-C.
    Cheon EP; Han HK
    Acta Pharmacol Sin; 2007 Feb; 28(2):268-72. PubMed ID: 17241530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
    Schwendener R; Schott H
    Methods Enzymol; 2005; 391():58-70. PubMed ID: 15721374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.